Capital News

Alzheimer’s Disease Epidemiology Forecast Report 2030 | Alzheimer’s Disease Epidemiology Analysis 2030 | DelveInsight

 Breaking News
  • No posts were found

Alzheimer’s Disease Epidemiology Forecast Report 2030 | Alzheimer’s Disease Epidemiology Analysis 2030 | DelveInsight

September 08
07:26 2021
Alzheimer's Disease Epidemiology Forecast Report 2030 | Alzheimer's Disease Epidemiology Analysis 2030 | DelveInsight
DelveInsight Business Research LLP
DelveInsight’s ‘Alzheimer’s disease (AD) – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Alzheimer’s disease (AD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

DelveInsight launched a new report on Alzheimer’s Disease Epidemiology Forecast, 2030.

Alzheimer’s disease is a debilitating neurological disorder that gradually erodes memory and cognitive abilities, as well as the ability to perform even the most basic tasks. Alzheimer’s patients have difficulty doing simple tasks such as driving a car, preparing a meal, or paying bills. They can repeatedly ask the same questions, become easily disoriented, accidentally drop or misplace objects, and find even simple things perplexing. Some people become worried, frustrated, or aggressive as the disease progresses.

DelveInsight’s Alzheimer’s Disease Epidemiology Forecast to 2030 report delivers an in-depth understanding of the disease, historical and forecasted Alzheimer’s Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Some of the key highlights from the Alzheimer’s Disease Epidemiology Report:

  1. Nearly one-half of patients with Alzheimer’s disease have moderate to severe disease (Yuan et al. 2021). Among people with Alzheimer’s disease, 50.4% had mild disease, 30.3% had moderate disease, and 19.3% had severe disease. This means that half of all cases could be categorized as mild.  

  2. According to Alzheimer’s Association (2018), the percentage of people with Alzheimer’s dementia increases with age: <5% of people aged 65–74, <20% of people aged 75–84, and >30% and <50% of people aged 85 and older have Alzheimer’s dementia. Out of these, more than 50% are aged 75 or older.

  3. The most recent national survey conducted in six regions of Japan reported the mean prevalence of dementia in people aged ≥65 years to be 15.75% (95% CI: 12.4, 22.2%), which is much higher than the previously estimated rate of 10% in 2010. Alzheimer’s Disease was confirmed as the predominant type of dementia, accounting for 65.8% of all cases. Advancing age and low education were the most consistently reported risk factors for Alzheimer’s Disease dementia. (Montgomery et al, 2018).

Visit for more @ Alzheimer’s Disease Epidemiology Insights

Scope of the Alzheimer’s Disease Epidemiology report:

  1. The Alzheimer’s Disease report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns

  2. The Alzheimer’s Disease Epidemiology Report and Model provide an overview of the risk factors and global trends of Alzheimer’s Disease in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)

  3. The report provides insight into the historical and forecasted patient pool of Alzheimer’s Disease in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan

  4. The report helps to recognize the growth opportunities in the 7MM concerning the patient population

  5. The report assesses the disease risk and burden and highlights the unmet needs of Alzheimer’s Disease

  6. The report provides the segmentation of the Alzheimer’s Disease epidemiology

Table of Contents:

1. Key Insights

2. Executive Summary of Alzheimer’s Disease

3. Alzheimer’s Disease Epidemiology Overview at a Glance

4. Alzheimer’s Disease: Disease Background and Overview

5. Epidemiology and Patient Population

6. Case Reports

7. Country Wise-Epidemiology of Alzheimer’s Disease 

8. Appendix

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Read more on Alzheimer’s Disease Epidemiological Insights

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/


Warning: count(): Parameter must be an array or an object that implements Countable in /home/capitalnews/public_html/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5
Share